Eye Movement Desensitization and Reprocessing (EMDR) in Complex Psychotrauma
NCT ID: NCT04594434
Last Updated: 2022-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
49 participants
INTERVENTIONAL
2020-12-12
2022-07-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
" Effect of Affordance of Objects on the Memory: Study in Transcranial Magnetic Stimulation "
NCT02956304
Cortical Excitability in Obsessive-Compulsive and Related Disorders
NCT00029068
Effects of Emotional Stimuli in Patients With Disorders of Consciousness
NCT03502837
Cybersickness imAgiNg Olfactory Evocation
NCT05308433
Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing Biases
NCT02079610
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be seen 16 times for the purposes of the study. They will be hospitalized during therapy. Discharge from hospitalization occurs during follow-up depending on the patient's condition.
They will be evaluated over a period of 4 to 6 weeks between the start (Day 0 = Week 1) and the end of treatment (visit week 12). These visits will coincide with treatment sessions with the EMDR ± SB / SMP protocol, as part of the support of their complex psychotrauma. At the end of treatment, the patient will be evaluated during follow-up visits at Month 1, Month 3 and Month 6.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
protocol EMDR + SB / SMP protocol (adjusted)
Association of a positive memory with the "recommended" therapy based on EMDR.
Scale SUD
Subjective Units of Distress Scale ou Subjective Units of Disturbance Scale is a scale of subjective appreciation of emotions
VOC scale
The VOC (Validity Of Cognition) scale is a scale of value given to cognition.
DES II scale
The Dissociative Experiences Scale (DES), which is translated as the Dissociative Experiences Scale, is a self-questionnaire to assess the frequency of various dissociative symptoms in the patient's daily life.
protocol EMDR (standard).
"recommended" therapy based on EMDR.
Scale SUD
Subjective Units of Distress Scale ou Subjective Units of Disturbance Scale is a scale of subjective appreciation of emotions
VOC scale
The VOC (Validity Of Cognition) scale is a scale of value given to cognition.
DES II scale
The Dissociative Experiences Scale (DES), which is translated as the Dissociative Experiences Scale, is a self-questionnaire to assess the frequency of various dissociative symptoms in the patient's daily life.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scale SUD
Subjective Units of Distress Scale ou Subjective Units of Disturbance Scale is a scale of subjective appreciation of emotions
VOC scale
The VOC (Validity Of Cognition) scale is a scale of value given to cognition.
DES II scale
The Dissociative Experiences Scale (DES), which is translated as the Dissociative Experiences Scale, is a self-questionnaire to assess the frequency of various dissociative symptoms in the patient's daily life.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having signed an informed consent form to participate in the study.
Exclusion Criteria
* Patient seeking legal benefit from participating in the study;
* Patient previously treated with EMDR;
* Patient unable to understand the information related to the study (linguistic, psychological, cognitive reason, etc.);
* Untreated epileptic patient;
* Patient with severe oculomotor disorders;
* Patient in hypomanic phase;
* Patient treated with high dose corticosteroids;
* Patient with alcohol and / or drug misuse in the 7 days preceding inclusion;
* Pregnant or likely to be (of childbearing age, without effective contraception) or breastfeeding;
* Patient participating in another clinical trial, or in a period of exclusion from another clinical trial;
* Patient not beneficiary of a social security scheme.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GCS Ramsay Santé pour l'Enseignement et la Recherche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique d'Yveline
Vieille-Église-en-Yvelines, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A01914-35
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.